lnterferon-α versus Somatostatin or the Combination of Both in Gastro-Enteropancreatic Tumours

Interferon-α (IFN-α) has a direct anti-tumour effect and is an immunomodulator. Somatostatin analogues, by contrast, when used to treat neuroendocrine tumours, control the secretion and peripheral eff